Abstract

Aim. To explore genesis of the left ventricle hypertrophy in acromegaly patient, with the method of next generation sequencing. Material and methods. Standard clinical and laboratory minimum was done, with electrocardiography, 24 hour ECG monitoring, echocardiography, magnete resonance tomography of the heart, new generation sequencing on the IlluminaHiSeq 2000 equipment with simultaneous analysis of 108 genes associated with idiopathic hypertrophic cardiomyopathy (HCMP) and phenocopies of HCMP. Results. At the age 59 y. o. the female patient had beed first time diagnosed with asymmetric HCMP, non-obstructive type (interventricular septum 19 mm, posterior wall 11 mm, pressure gradient in outflow tract of the left ventricle (OTLV) — 25 mmHg). At the age 62 y. o. she developed HCMP with dynamic obstruction of OTLV (pressure gradient in OTLV up to 80 mmHg) with progressing dyspnea on exertion, and required non-surgical reduction of interventricular septum. By the computed tomography data, at the age 63 y. o. the patient was diagnosed with endocellar hypophysis microadenoma (a tumor 6,7*7,3 mm), somatotropic hormone — 53,39 mU/L (normal: 0,1-20 mU/L), insulin-like growth factor 1 — 359 ng/mL (normal: 118-314 ng/mL). However, with retrospective analysis of her photos, even from the age 40 y. o. there were enlarged hands, feet, nasal cartilages, ears, lips and eyebrow arcs that witness for long lasting disease course. With the new generation sequencing, there were no pathological mutations revealed. Conclusion. The case represents hypertrophic cardiomyopathy as a leading clinical sign in acromegalic cardiomyopathy that imitated idiopathic HCMP. Patient management in such case should include on-time etiopathogenetic therapy that works against disease progression, and in some cases even for regression of the left ventricle hypertrophy.

Highlights

  • The case represents hypertrophic cardiomyopathy as a leading clinical sign in acromegalic cardiomyopathy that imitated idiopathic HCMP. Patient management in such case should include on-time etiopathogenetic therapy that works against disease progression, and in some cases even for regression of the left ventricle hypertrophy

  • У нашей пациентки длительно существующая акромегалия без своевременно проводимой специфической терапии вызвала развитие гипертрофии миокарда с динамической обструкцией выносящего тракта левого желудочка и появление клиники хронической сердечной недостаточности, что привело к необходимости выполнения нехирургической редукции МЖП

Read more

Summary

КЛИНИЧЕСКИЕ СЛУЧАИ

АКРОМЕГАЛИЧЕСКАЯ КАРДИОМИОПАТИЯ С ДИНАМИЧЕСКОЙ ОБСТРУКЦИЕЙ ВЫНОСЯЩЕГО ТРАКТА ЛЕВОГО ЖЕЛУДОЧКА. Проведен стандартный клинико-лабораторный минимум, электрокардиография, суточное мониторирование электрокардиографии, эхокардиография, магнитно-резонансная томография сердца, секвенирование нового поколения на аппарате Illumina HiSeq 2000 с одномоментным анализом 108 генов, ассоциированных с идиопатической гипертрофической кардиомиопатией (ГКМП) и фенокопиями ГКМП. ВТЛЖ — выносящий тракт левого желудочка, ГКМП — гипертрофическая кардиомиопатия, ГЛЖ — гипертрофия левого желудочка, ЗС ЛЖ — задняя стенка левого желудочка, ИФР-1 — инсулиноподобный фактор роста 1, МЖП — межжелудочковая перегородка, ИММ ЛЖ — индекс массы миокарда левого желудочка, МРТ — магнитно-резонансная томография, СМЭКГ — суточное мониторирование электрокардиографии, СТГ — соматотропный гормон, ЭКГ — электрокардиография. Patient management in such case should include on-time etiopathogenetic therapy that works against disease progression, and in some cases even for regression of the left ventricle hypertrophy. КТ головного мозга без в/в контрастирования: патологические образования не выявлены -

Лечение не проводилось
Терапия прежняя
Градиент в ВТ ЛЖ при пробе
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.